Back to results
US 10,946,083 B2Granted
Anti-microbial immunomodulation
AssigneeQu Biologies Inc.
InventorsHarold David Gunn, Salim Dhanji, David W. Mullins
Life of this patent
Estimating the term…
Abstract
The invention provides methods of modulating an immune system in a vertebrate host for the therapeutic or prophylactic treatment of infection by a first microbial pathogen in a target tissue, comprising administration at an administration site of an effective amount of an antigenic formulation comprising antigenic determinants specific for a second heterologous microbial pathogen.
Claims20
A method of modulating an immune system in a vertebrate host for the prophylactic [or therapeutic]treatment of infection by a first microbial pathogen in a target tissue, the method comprising:
- administering to the vertebrate host an effective amount of an antigenic formulation comprising antigenic determinants specific for a second heterologous microbial pathogen, wherein:
- the antigenic determinants are selected from the group consisting of whole cells or cell wall extracts;
- the first microbial pathogen is a microbial lung pathogen that is not a Klebsiella pneumonia, Streptococcus pneumonia, Pseudomonas aeruginosa or a viral lung pathogen, and the second heterologous microbial pathogen is a Klebsiella pneumonia, and the target tissue is the lung;
- and,
- wherein the administering comprises administering successive doses of the formulation at a dosage interval of at least one hour, so that two or more doses are administered over a period from 2 days to 1 month, over a dosage duration of at least one week.
2 more elements
Dependencies are inferred from the claim text.